BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Miyazaki M, Kimura F, Shimizu H, Yoshidome H, Otsuka M, Kato A, Hideyuki Y, Nozawa S, Furukawa K, Mituhashi N. Extensive hilar bile duct resection using a transhepatic approach for patients with hepatic hilar bile duct diseases. Am J Surg. 2008;196:125-129. [PMID: 18466867 DOI: 10.1016/j.amjsurg.2007.04.020] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Hartog H, Ijzermans JN, van Gulik TM, Koerkamp BG. Resection of Perihilar Cholangiocarcinoma. Surgical Clinics of North America 2016;96:247-67. [DOI: 10.1016/j.suc.2015.12.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
2 Kuriyama N, Usui M, Gyoten K, Hayasaki A, Fujii T, Iizawa Y, Kato H, Murata Y, Tanemura A, Kishiwada M, Sakurai H, Mizuno S, Isaji S. Neoadjuvant chemotherapy followed by curative-intent surgery for perihilar cholangiocarcinoma based on its anatomical resectability classification and lymph node status. BMC Cancer 2020;20:405. [PMID: 32393197 DOI: 10.1186/s12885-020-06895-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Shah SR. Issues in surgery for hilar cholangiocarcinoma. Indian J Surg 2012;74:87-90. [PMID: 23372312 DOI: 10.1007/s12262-011-0382-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
4 Kuriyama N, Isaji S, Tanemura A, Iizawa Y, Kato H, Murata Y, Azumi Y, Kishiwada M, Mizuno S, Usui M, Sakurai H. Transhepatic Hilar Approach for Perihilar Cholangiocarcinoma: Significance of Early Judgment of Resectability and Safe Vascular Reconstruction. J Gastrointest Surg 2017;21:590-9. [PMID: 27896655 DOI: 10.1007/s11605-016-3332-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
5 Li CX, Zhang H, Wang K, Wang X, Li XC. Preoperative Bilirubin Level Predicts Overall Survival and Tumor Recurrence After Resection for Perihilar Cholangiocarcinoma Patients. Cancer Manag Res 2019;11:10157-65. [PMID: 31819648 DOI: 10.2147/CMAR.S230620] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Miyazaki M, Kimura F, Shimizu H, Yoshidome H, Otuka M, Kato A, Yoshitomi H, Furukawa K, Takeuchi D, Takayashiki T, Suda K, Takano S. One hundred seven consecutive surgical resections for hilar cholangiocarcinoma of Bismuth types II, III, IV between 2001 and 2008. J Hepatobiliary Pancreat Sci 2010;17:470-5. [PMID: 19936600 DOI: 10.1007/s00534-009-0207-2] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 3.6] [Reference Citation Analysis]
7 Xu X, Yang L, Chen W, He M. Transhepatic hilar approach for Bismuth types III and IV perihilar cholangiocarcinoma with long-term outcomes. J Int Med Res 2021;49:3000605211008336. [PMID: 33983055 DOI: 10.1177/03000605211008336] [Reference Citation Analysis]
8 Shi Z, Yang MZ, He QL, Ou RW, Chen YT. Addition of hepatectomy decreases liver recurrence and leads to long survival in hilar cholangiocarcinoma. World J Gastroenterol 2009; 15(15): 1892-1896 [PMID: 19370789 DOI: 10.3748/wjg.15.1892] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
9 Gao JB, Bai LS, Hu ZJ, Wu JW, Chai XQ. Role of Kasai procedure in surgery of hilar bile duct strictures. World J Gastroenterol 2011; 17(37): 4231-4234 [PMID: 22072856 DOI: 10.3748/wjg.v17.i37.4231] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
10 Lee SG, Song GW, Hwang S, Ha TY, Moon DB, Jung DH, Kim KH, Ahn CS, Kim MH, Lee SK. Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience. J Hepatobiliary Pancreat Sci. 2010;17:476-489. [PMID: 19851704 DOI: 10.1007/s00534-009-0204-5] [Cited by in Crossref: 165] [Cited by in F6Publishing: 145] [Article Influence: 12.7] [Reference Citation Analysis]
11 Yamanaka K, Iizuka N, Kitai T. A case of pancreaticoduodenectomy and partial hepatic resection as repeat cytoreductive surgery for recurrent pseudomyxoma peritonei. Surg Case Rep 2021;7:251. [PMID: 34862939 DOI: 10.1186/s40792-021-01332-2] [Reference Citation Analysis]
12 Sano T, Shimizu Y, Senda Y, Komori K, Ito S, Abe T, Kinoshita T, Nimura Y. Isolated caudate lobectomy with pancreatoduodenectomy for a bile duct cancer. Langenbecks Arch Surg 2013;398:1145-50. [PMID: 24026222 DOI: 10.1007/s00423-013-1110-5] [Reference Citation Analysis]
13 Ohtsuka M, Shimizu H, Kato A, Yoshitomi H, Furukawa K, Tsuyuguchi T, Sakai Y, Yokosuka O, Miyazaki M. Intraductal papillary neoplasms of the bile duct. Int J Hepatol. 2014;2014:459091. [PMID: 24949206 DOI: 10.1155/2014/459091] [Cited by in Crossref: 70] [Cited by in F6Publishing: 55] [Article Influence: 8.8] [Reference Citation Analysis]
14 Ohtsuka M, Kimura F, Shimizu H, Yoshidome H, Kato A, Yoshitomi H, Furukawa K, Mitsuhashi N, Takeuchi D, Takayashiki T. Surgical strategy for mucin-producing bile duct tumor. J Hepatobiliary Pancreat Sci. 2010;17:236-240. [PMID: 19649559 DOI: 10.1007/s00534-009-0152-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
15 Park HJ, Kim SY, Kim HJ, Lee SS, Hong GS, Byun JH, Hong SM, Lee MG. Intraductal Papillary Neoplasm of the Bile Duct: Clinical, Imaging, and Pathologic Features. AJR Am J Roentgenol. 2018;211:67-75. [PMID: 29629808 DOI: 10.2214/ajr.17.19261] [Cited by in Crossref: 27] [Cited by in F6Publishing: 10] [Article Influence: 6.8] [Reference Citation Analysis]